Skip to Main Content

Advertisement intended for health care professionals

American Society of Hematology Logo Open Menu
Cart
header search
Search
Skip Nav Destination

Literature Scan

New and noteworthy research from the medical literature landscape
Cilta-Cel Shows Superior Efficacy, Survival Over Ide-Cel, but Higher Toxicity in R/R MM Free
Katie Robinson
May 28, 2025
24-Hour Urine-Based Response Test Not Necessary for MM Free
Leah Lawrence
May 28, 2025
Large Study Clarifies Risk of Thrombosis Associated With Protein S Deficiency Free
Anna Azvolinsky, PhD
May 22, 2025
Analysis Offers Insight Into CAR-T-Related Secondary Malignancies Free
Thomas R. Collins
May 22, 2025
Combination Pelabresib-Ruxolitinib Shows Disease Burden Benefit in Patients With Myelofibrosis Free
Khylia Marshall
May 22, 2025
Daratumumab-Containing Quadruplet Effective as First-Line in Transplant-Ineligible NDMM, Randomized Trial Finds Free
Thomas R. Collins
May 1, 2025
Fixed-Duration Acalabrutinib Combinations Effective for Untreated CLL Free
Lara C. Pullen, PhD
May 1, 2025
Intensive Factor VIII Prophylaxis May Benefit Patients with Hemophilia, Hypertrophic Synovium Free
Ruth Jessen Hickman, MD
May 1, 2025
Abelacimab Demonstrates Safety, Superior Bleeding Reduction Compared With Rivaroxaban in Atrial Fibrillation Free
Khylia Marshall
April 10, 2025
Clonal Hematopoiesis Linked to Increased Risk for Heart Failure, Non-Relapse Mortality After AHCT for Lymphoma Free
Katie Robinson
April 10, 2025
BCMA-Targeting CAR-T With Innovative Manufacturing Process Shows Early Activity for R/R MM Free
Leah Lawrence
April 10, 2025
Short-Term Benefit Seen With Tranexamic Acid in Hemarthrosis, but Questions Persist Free
Thomas R. Collins
April 10, 2025
Altered T-Cell Subsets, Lower Lymphocyte Counts Found in Carriers of Sickle Cell Trait Free
Ruth Jessen Hickman, MD
March 29, 2025
miRNA Identified as Potential ITP Diagnostic Biomarker Free
Leah Lawrence
March 29, 2025
Post-Transplant Mutation Clearance Important Indicator of Prognosis for Myelofibrosis Free
Leah Lawrence
March 29, 2025
Talquetamab Plus Teclistamab Effective for Relapsed or Refractory Multiple Myeloma Free
Lara C. Pullen, PhD
March 29, 2025
Study Suggests Disparities in MM Outcomes Persist on a Global Scale Free
Khylia Marshall
March 12, 2025
Non-Transplant Salvage Therapy Safe for Pediatric, Adolescent Patients with R/R cHL Free
Anna Azvolinsky, PhD
March 12, 2025
Pacritinib Response Linked to Survival in Myelofibrosis With Thrombocytopenia Free
Katie Robinson
March 5, 2025
Study Maps Clinical Evolution of Fanconi Anemia Using Large Patient Registry Free
Anna Azvolinsky, PhD
February 26, 2025

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
June 2025

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2025 by American Society of Hematology
 
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals